AbbVie Inc. (ABBV) Pops 2.85% for December 22

Equities Staff |

One of the S&P 500’s big winners for Tuesday December 22 was AbbVie Inc. (ABBV) as the company’s stock climbed 2.85% to $57.80 on volume of 6.22 million shares.

The stock opened at $56.54 and saw an intraday low of $56.42 and an intraday high of $57.99. All told, the day saw a per-share gain of $1.6. The stock’s average daily volume of 10.45 million and 1.63 billion shares outstanding. AbbVie Inc. now has a 50-day SMA is $57.68 and 200-day SMA is $61.76, and it has a 52-week high of $71.60 and a 52-week low of $45.45.

AbbVie Inc is a research-based biopharmaceutical company. Its products are used to treat diseases including rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis complications.

Based out of North Chicago, IL, AbbVie Inc. has 28,000 employees and, after today’s trading, reached a market cap of $94.49 billion. Its P/S ratio is n/a, P/B ratio is 19.46, and P/FCF ratio is -9.

For a complete fundamental analysis analysis of AbbVie Inc., check out’s Stock Valuation Analysis report for ABBV. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Viking Investments Gp Inc

Viking Investments Group Inc provides professional advisory and consulting services to companies undergoing or anticipating periods of rapid growth, change or ownership transition.

Private Markets

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…